Charanjit Aulakh

Array ( [id] => 8177312 [patent_doc_number] => 08178551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson\'S disease prevention or treatment' [patent_app_type] => utility [patent_app_number] => 12/530444 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21517 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178551.pdf [firstpage_image] =>[orig_patent_app_number] => 12530444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4699144 [patent_doc_number] => 20080221328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'LUMINESCENT LANTHANIDE COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/041338 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3543 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221328.pdf [firstpage_image] =>[orig_patent_app_number] => 12041338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752552 [patent_doc_number] => 20080160627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection' [patent_app_type] => utility [patent_app_number] => 12/040850 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20030 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160627.pdf [firstpage_image] =>[orig_patent_app_number] => 12040850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103269 [patent_doc_number] => 07723536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof' [patent_app_type] => utility [patent_app_number] => 12/072730 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 53 [patent_no_of_words] => 70495 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723536.pdf [firstpage_image] =>[orig_patent_app_number] => 12072730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774427 [patent_doc_number] => 08119654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Indenoisoquinolinone analogs and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/039611 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 135815 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119654.pdf [firstpage_image] =>[orig_patent_app_number] => 12039611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685323 [patent_doc_number] => 20100120818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'SUBSTITUTED TETRAHYDROPYRROLOQUINOLINES' [patent_app_type] => utility [patent_app_number] => 12/531947 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11527 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120818.pdf [firstpage_image] =>[orig_patent_app_number] => 12531947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4814040 [patent_doc_number] => 20080194671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Method for treating atherosclerosis or restenosis using microtubule stabilizing agent' [patent_app_type] => utility [patent_app_number] => 12/072067 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5770 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194671.pdf [firstpage_image] =>[orig_patent_app_number] => 12072067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560241 [patent_doc_number] => 08334305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase' [patent_app_type] => utility [patent_app_number] => 12/528227 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49948 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12528227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223096 [patent_doc_number] => 20100056556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'ISOQUINOLINOPYRROLOPYRIDINONES ACTIVE AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/528656 [patent_app_country] => US [patent_app_date] => 2008-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10468 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056556.pdf [firstpage_image] =>[orig_patent_app_number] => 12528656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446489 [patent_doc_number] => 08288542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Noble ruthenium-type sensitizer and method of preparing the same' [patent_app_type] => utility [patent_app_number] => 12/527767 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7224 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741174 [patent_doc_number] => 08106199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Organometallic materials for optical emission, optical absorption, and devices including organometallic materials' [patent_app_type] => utility [patent_app_number] => 12/030798 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 4212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106199.pdf [firstpage_image] =>[orig_patent_app_number] => 12030798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283071 [patent_doc_number] => 08217173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Fluoride-releasing compositions' [patent_app_type] => utility [patent_app_number] => 12/526321 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9884 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12526321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 152279 [patent_doc_number] => 07678906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Process for making triphenylboron-pyridine compound' [patent_app_type] => utility [patent_app_number] => 12/027432 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4076 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678906.pdf [firstpage_image] =>[orig_patent_app_number] => 12027432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8876056 [patent_doc_number] => 08471022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Preparation and use of (R),(R)-2,2′-bis-methylnaltrexone' [patent_app_type] => utility [patent_app_number] => 12/865915 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6010 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786180 [patent_doc_number] => 20080139509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'PANCRATISTATIN CYCLIC PHOSPHATE PRODRUGS AND PHENPANSTATIN CYCLIC PHOSPHATE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/025525 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9279 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139509.pdf [firstpage_image] =>[orig_patent_app_number] => 12025525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289100 [patent_doc_number] => 07547714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Tricyclic compounds, compositions, and methods' [patent_app_type] => utility [patent_app_number] => 12/023323 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18144 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547714.pdf [firstpage_image] =>[orig_patent_app_number] => 12023323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955419 [patent_doc_number] => 20080188443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Tricyclic Compound, Compositions, and Methods' [patent_app_type] => utility [patent_app_number] => 12/023362 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18150 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188443.pdf [firstpage_image] =>[orig_patent_app_number] => 12023362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685411 [patent_doc_number] => 20100120730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => '6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/449173 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22999 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120730.pdf [firstpage_image] =>[orig_patent_app_number] => 12449173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899890 [patent_doc_number] => 20080119504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'NEW APORPHINE ESTERS AND THEIR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/021560 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10545 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119504.pdf [firstpage_image] =>[orig_patent_app_number] => 12021560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257856 [patent_doc_number] => 08207337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Reagent for organic synthesis reaction containing organic triol borate salt' [patent_app_type] => utility [patent_app_number] => 12/524821 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14007 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524821 [rel_patent_id] =>[rel_patent_doc_number] =>)